Orchid Cellmark Reports 15.4-Percent Decline in Q4 Revenues as Profits Turn to Loss | GenomeWeb

NEW YORK, May 19 (GenomeWeb News) - Orchid Cellmark reported today a 15.4-percent decrease in revenues and a 5.5-percent decrease in net income for the fourth quarter of 2005.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.